EU/3/15/1474: Orphan designation for the treatment of Stargardt's disease

Ecothiopate iodide


Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2020 on request of the Sponsor.

On 24 April 2015, orphan designation (EU/3/15/1474) was granted by the European Commission to JJGConsultancy Ltd, United Kingdom, for ecothiopate iodide for the treatment of Stargardt's disease.

Key facts

Active substance
Ecothiopate iodide
Intended use
Treatment of Stargardt's disease
Orphan designation status
EU designation number
Date of designation
JJGConsultancy Ltd
Sherston House
High Street
Somerset BA4 6HZ
United Kingdom
Tel. +44 (0)1749 838886
Fax +44 (0)1749 838887

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Documents related to this orphan designation evaluation

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

EU register of orphan medicines

The list of medicines that have received an orphan designation in the EU is available on the European Commission's website:

How useful was this page?

Add your rating